Stocks/AVTX

AVTX three-lens brief

Evidence-based stock research on AVTX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of 07:00 ET
$6.53$8.51$24.27

Performance

1W
+20.4%
1M
-35.7%
3M
-56.2%
6M
—
YTD
—
1Y
—
3Y
—
5Y
—
AVTX · Nightly brief
Concern

Price up 18.85% in the last session — a material single-day move. · Trading at 11% of its 52-week range — deep in the lower band.

  • Price up 18.85% in the last session — a material single-day move.
  • Trading at 11% of its 52-week range — deep in the lower band.
  • 50-day MA below 200-day MA (death-cross regime); price below both.
  • Underperforming SPY by 44.1pp over 30 days.
  • P/E of 2.3 — trading at a value multiple.

AVTX closed at $8.51 (+18.85%) as of 2026-11-12. Market cap: $492.07M. P/E (trailing) 2.3. Price is below the 50-day MA and below the 200-day MA. Positives: price up 18.85% in the last session — a material single-day move.; p/E of 2.3 — trading at a value multiple.. Concerns: trading at 11% of its 52-week range — deep in the lower band.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $59.0K, net income -$18.95M, free cash flow -$19.38M.

Market ✓· Fundamentals ✓· 1 events
Informational only · Not investment advice
Three-lens method

Why three lenses on AVTX, not one.

A single reasoning model has blind spots it doesn’t know about. We examine AVTX across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://www.clearpathinvest.app/embed/AVTX"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath AVTX brief"></iframe>